2m 2m 2m 2m 2m 2m 2m
Lexaria Bioscien (LEXX)
NASDAQ
$0.60+$0.007 (+1.19%)
Price as of Jul 14, 2026 8:23 AM EDT- $14.7MMarket Cap
- -28.68%1-Year Change
- BiotechnologyIndustry
Lexaria Bioscien (LEXX)
$0.60+$0.007 (+1.19%)
LEXX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | -$0.05 (-8.00%) | ||
Open | $0.68 | ||
High | $0.68 | ||
Low | $0.57 | ||
Previous Close | $0.65 | ||
Volume | 62,676 | ||
30-Day Average Volume | 64,315 | ||
1-Week Change | 6.33% | ||
1-Month Change | -3.19% | ||
1-Year Change | -28.68% | ||
3-Year Change | -28.33% | ||
5-Year Change | -91.28% | ||
Fundamentals | |||
Shares Outstanding | 24.8M | ||
Total Assets | $4.8M | ||
Market Cap | $14.7M | ||
Enterprise Value | $11.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.6M | ||
EBIT | -$2.0M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $3.7M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue